Abiopharma

🔍 Harris Taylor C. (Director)

Company: ESTABLISHMENT LABS HOLDINGS INC. (ESTA)

Report Date: 2026-06-24

Detailed Transactions and Holdings:

• Acquired 1,949 shares of Common Shares (Direct)
  Date: 2026-06-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,949.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,281 shares of Common Shares (Direct)
  Date: 2026-06-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,230.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents an award of stock units under the Issuer's 2018 Equity Incentive Plan. The shares subject to the award vest as to 1/3 of the shares subject to the initial award on the yearly anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date.
• F2: Represents an award of stock units under the Issuer's 2018 Equity Incentive Plan. The shares subject to the award vest in full on the earlier of June 24, 2027 or the day prior to the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through such date.